Human Immunoglobulin(Boya Biopharmaceutical)

人免疫球蛋白(博雅生物)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman Immunoglobulin(Boya Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency SyndromesAgammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A